Skip to Content

OLAPARIB 50 mg Logo (Lynparza 50 mg)

Generic Name: olaparib

Pill with imprint OLAPARIB 50 mg Logo is White, Capsule-shape and has been identified as Lynparza 50 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Lynparza is used in the treatment of ovarian cancer; breast cancer, metastatic and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for OLAPARIB 50 mg Logo

Lynparza

Generic Name:
olaparib
Imprint:
OLAPARIB 50 mg Logo
Strength:
50 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
PARP inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC):
00310-0657

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide